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TO ESTIMATE THE PREVALENCE OF RENAL DYSFUNCTION IN 
PATIENTS WITH CHRONIC OBSTRUCTIVE  
PULMONARY DISEASE 
INTRODUCTION: 
The association between COPD and renal dysfunction has not been 
frequently assessed. Lean mass is frequently reduced in COPD, and the 
glomerular filtration rate (GFR) might be depressed in spite of normal serum 
creatinine (concealed CRF-Chronic Renal Failure). We investigated the 
prevalence and correlates of both concealed and overt CRF in patients with 
COPD. 
MATERIALS AND METHODS: 
         During the period of may 2017 to April 2018, a cross sectional 
observational study was done.364 patients who were diagnosed as COPD were 
included in the study. In all the 364 cases, GFR was estimated using the 2009 
CKD-EPI creatinine equation. Patients were categorized as having normal renal 
function, concealed CRF (normal serum creatinine and reduced GFR), or overt 
CRF (increased serum creatinine and reduced GFR).Independent correlates of 
CRF were investigated by logistic regression analysis. 
RESULTS: 
The prevalence of concealed and overt CRF in patients with COPD was 
6.6% and 18.4% respectively. Significant risk factors associated with the 
development of renal dysfunction are Age>60, mMRC grade ≥2, FEV1% 
≤50% (GOLD 3 and 4), Smokers with pack years > 40. Associations between 
explanatory variables and renal failure were examined by a logistic regression 
analysis. 
 
CONCLUSION: 
            Renal dysfunction should be considered a comorbidity of COPD, and it 
should be screened for because its recognition might either directly affect 
clinical practice or have prognostic implications. Within the context of the 
rising interest in systemic features of COPD and related comorbidities,Renal 
dysfunction should not be ignored because it frequently cannot be recognized 
on the basis of serum creatinine. 
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